SCOPE OF THE PROBLEM

Definitions of Invasive Candidiasis
Diagnosis of infections due to Candida species presents unique problems. These organisms commonly colonize human skin and mucous membranes so that merely isolating them in culture specimens from these sites is not proof of invasion (82) . In acute cutaneous candidiasis, organisms penetrate only the outer layers of the squamous stratum corneum of the skin. A pustular dermatitis results that actually more resembles a hypersensitivity reaction than an infection (68) . Because of this, the term invasive candidiasis is commonly used to denote penetration of Candida spp. into tissues below epithelial surfaces or infection of viscera. This term distinguishes these more serious infections from heavy colonization with or without superficial penetration of an epithelial barrier. Most researchers studying candidiasis have developed case definitions of invasive candidiasis which are used to assess the utility of a particular diagnostic or therapeutic approach to the infection. These case definitions may influence the reported sensitivity and specificity of a diagnostic test. Most would agree that invasive candidiasis is present when Candida organisms are recovered from multiple blood cultures drawn over a period of days, when the organism is cultured from or demonstrated histologically in tissue biopsies, or when it is recovered from a normally sterile fluid such as cerebrospinal or joint fluid. However, clinicians frequently encounter situations that are much less clear than these, when the diagnosis may be considered likely enough for therapeutic intervention even though it is not proven, for example, a patient with only a single positive blood culture for a Candida sp. and retinal lesions typical of those seen with bloodborne dissemination to the eye or a febrile patient who has failed to respond to antibacterial drugs who has the organism growing from multiple sites including abdominal drains placed during surgery. Clinical correlations between laboratory findings and the patient's condition are essential to diagnose invasive candidiasis accurately. Physicians may need to rely on cumulative information from multiple specimens to have enough confidence to begin antifungal therapy for invasive candidiasis.
Taxonomy and Growth Characteristics
The genus Candida is one of the most important genera of medically important yeasts. Although any Candida species can produce human disease, Candida albicans is the most important pathogen, followed by C. tropicalis (76, 82, 94) . Except when otherwise indicated, the term candidiasis will refer to infections produced by members of the genus Candida. There has been a debate among mycologists with respect to whether or not the genera Candida and Torulopsis should be fused into a single genus. Recently, it has been recommended that the medically important yeast Torulopsis glabrata be renamed Candida glabrata. The arguments for and against this are summarized well in the recently published monograph by Odds (82) . The Manual of Clinical appropriate conditions. Pseudomycelia are formed when blastoconidia produce elongated buds that do not split off but remain attached to neighboring cells. Diminished oxygen tension, 5 to 10% carbon dioxide, 370C incubation temperature, relative glucose starvation, and a rich protein milieu favor pseudohypha production, explaining the fuzzy appearance beneath colonies of Candida spp. growing on the surface of blood agar. These conditions also favor germ tube production by C. albicans and C. stellatoidea. Germ tubes are cylindrical filamentous structures that sprout from the side of a blastospore, grow at their tips, and show no indentation at their site of attachment to the blastospore. On suitable laboratory media, C. albicans germ tube growth can lead to production of a mycelium bearing chlamydospores.
The surface of host mucous membranes and tissues provides conditions favoring production of pseudomycelia and germ tubes so that these filamentous growth forms are commonly encountered in Gram-stained smears from patient specimens. The organisms are variable in their staining reaction but are predominantly gram positive. In host tissues, filamentous forms undoubtedly enhance tissue penetration; however, the yeast's morphology in Gram-stained smears cannot be used to determine whether or not the specimen is from a site of tissue invasion. The filamentous growth form simply reflects the milieu in which the organism is growing.
Spectrum of Candida Infections
By the first two decades of the 20th century, the broad spectrum of Candida infections was being appreciated. Trivial self-limited or readily treatable mucocutaneous infections are common throughout the world (51) . Rare genetic defects in immune response are manifested by chronic mucocutaneous candidiasis. In the past three decades, with the use of potent antibacterial, immunosuppressive, and cytotoxic drugs, lethal invasive candidiasis in compromised hosts has been described with increasing frequency (78, 93) . These infections have sparked great interest in all aspects of Candida infections, including their diagnosis.
The many types of Candida infections and the diverse clinical settings in which they are found would seem to make it impossible to classify them in any meaningful way. However, certain useful generalities apply. C. albicans is part of the flora of the birth canal, and it colonizes the intertriginous skin and the gastrointestinal tract soon after birth. The largest pool of this organism within the host is in the gastrointestinal tract (82) . Because it is an aerobe, it most likely resides in the gut lumen close to mucous membrane surfaces where it scavenges oxygen from the mucosa. The organism is clearly poised to invade the host if defects in cutaneous or mucosal barriers occur. Defects in T-lymphocyte immunity (congenital or acquired defects, as in acquired immunodeficiency syndrome) or qualitative defects in neutrophil function (myeloperoxidase deficiency) are associated with chronic mucocutaneous infections. Patients with these defects can adequately halt proliferation and invasion of the organism but cannot eliminate it from the skin or mucous membranes. Thus, invasion deeper than the skin or mucous membranes and bloodborne dissemination occur rarely in these patients.
Deeply invasive infections with dissemination occur readily when an epithelial barrier is completely breached by the fungus or when quantitative defects in neutrophil function are present. The latter can be defined as a peripheral blood neutrophil count of <500/mm3. Infections produced after a gross breakdown of a normal epithelial barrier are encountered most frequently in surgical and intensive care unit patients. For example, the epithelial barrier may be breached when the organism tracks along the external surface of an intravascular catheter or is introduced directly through it into the bloodstream (63) . Leakage of a surgical enteral anastomosis with soilage of the peritoneal cavity is a more obvious example of breakdown of the normal mucosal barrier (106) (33, 80) . When fungi invade capillaries and veins of the gut wall, they can enter the portal venous blood and be conveyed to the liver. The liver acts as a strong barrier to dissemination because its macrophages are very efficient in removing Candida spp. (7, 50, 99, 114) . Therefore, few organisms may reach the heart and systemic circulation, and detection of Candida spp. in peripheral blood cultures of these patients is difficult. Although few yeast cells may be circulating in the bloodstream, paradoxically, those Candida cells that reach distant sites proliferate readily because of the profound neutropenia. Thus, severe disseminated disease can occur even though blood cultures are negative.
USE OF CULTURES IN DIAGNOSIS
Need for Identifying Candida Isolates to Species Most large hospitals and clinics in the United States now treat significant numbers of immunosuppressed patients, the population in which invasive candidiasis is frequently encountered. Many laboratories have not routinely identified Candida isolates to species, but the growing importance of severe candidiasis has made it necessary for them to do so. When coupled with information about the patient's risk factors, species identification can provide a diagnostic clue to the source of infection. For example, C. albicans, C. tropicalis, and C. krusei are most capable of colonizing and invading the gastrointestinal tract and producing bloodborne dissemination (74, 76, 121) . C. parapsilosis is adept at colonizing skin, intravascular devices, and equipment used to administer parenteral fluids (108, 109) . Outbreaks of C. parapsilosis fungemia associated with parenteral nutrition have been described (109) . C. lusitaniae is now emerging as an opportunist and can be relatively resistant to amphotericin B (45) . This organism can be misidentified as C. tropicalis, C. parapsilosis, and even Saccharomyces cerevisiae unless careful species identification is done.
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Detailed protocols for identification have been described (22) (16, 107) . Thus, reports of growth from multiple sites may prompt topical or even systemic therapy for some patients.
Pulmonary candidiasis occurs rarely in immunosuppressed patients and almost never in normal hosts. It was encountered in <3% of autopsies reported from several major cancer treatment centers in the late 1970s (97) . Authors of the three most complete reviews of clinical experience with pulmonary candidiasis (70, 77, 97) have all emphasized that isolation of Candida spp. from sputa cannot be used to diagnose pulmonary candidiasis. Because endotracheal tubes will be colonized with oropharyngeal flora, they considered that isolation of Candida spp. from endotracheal secretions is also not a useful diagnostic criterion.
The 10 ,000 to 40,000 C. albicans per ml with a mean of 22,000/ml (128) . In ten patients with no renal pathology, specimens grew 2,000 to 15,000 C. albicans per ml. However, in patients with long-term indwelling Foley catheters, up to 100,000 CFU/ml were seen in patients with or without documented renal candidiasis (128) . In intensive care unit patients with a Foley catheter in place, the presence of >100,000 Candida spp. per ml along with numerous leukocytes or erythrocytes may be an indication for continuous or intermittent bladder irrigation with amphotericin B. In a prospective study of urine cultures from hospitalized patients, Candida spp. were noted in the urine of a significant number of patients who had no symptoms of invasive candidiasis (95) . Thus, although the diagnosis of a urinary tract infection should be considered in a patient having >10,000 Candida organisms per ml of urine, clinical correlation is essential in interpreting any urine culture positive for Candida spp. Some (65) have claimed that candiduria in a neutropenic leukemic patient is evidence of bloodborne dissemination. There is no evidence for this assertion, which is based mainly on studies in mice injected intravenously with C. albicans (66) . In these animals, miliary abscesses develop in their kidneys and resolve slowly.
Diagnosis of Candida retinitis can present problems. This infection is bloodborne and begins as a lesion in the choroid layer of the retina, usually in an area in the posterior one-half of the eye. Growing organisms and necrotic debris project into the gelatinous vitreous humor overlying the retina to give the fluffy lesions seen on ophthalmoscopy (31 Fungal peritonitis is a well-documented complication of chronic ambulatory peritoneal dialysis (32) . It is important to distinguish between a contaminant introduced into the specimen from manipulation of the dialysis equipment and an organism actually resident in the fluid. For this reason, fluid should be spun and cultured both in broth and on plates.
Some think that these specimens are so prone to contamination that a second specimen should be submitted when one is positive to verify that infection is truly present (4 (127) recently described two patients with hematologic malignancies in whom blood cultures drawn from Broviac or Hickman catheters grew 14 to >100 CFU of Candida spp. per ml, whereas cultures drawn from peripheral veins had only 0.1 to 0.2 CFU/ml. Thus, they thought that the lysis-centrifugation technique enabled diagnosis of fungemia related to an infected intravascular device. In a conflicting study, Paya et al. (88) cultured blood simultaneously from a peripheral vein and intravascular devices by using the lysis-centrifugation technique during septic episodes in 44 patients. Of 52 intravascular cannulae studied, 15 were the cause of bacteremia or fungemia but only 7 of these showed a significantly higher bacterial count in blood obtained through the device as compared with peripheral blood. In the one patient with sepsis due to C. albicans, both blood specimens showed <10 CFU/ml. Bacterial counts were higher in blood drawn through the device than in peripheral blood in four of six cases that did not fulfill their definition of intravascular device-related bacteremia. Thus, data regarding the usefulness of lysis-centrifugation cultures in diagnosing intravascular device-related fungemia are conflicting and very limited.
Several studies have concluded that the Isolator is more sensitive in detecting fungi other than Candida spp. in blood (10, 12, 43) . However, setting up an Isolator culture in the microbiology laboratory requires more time than placing BACTEC bottles in the automated screening instrument. Individual laboratories need to decide whether the greater sensitivity of the lysis-centrifugation technique in detecting fungi warrants its use for routine blood culturing. Depending on the patient populations in its hospital and work load, a laboratory may choose to use only broth cultures, to use broth cultures routinely and lysis-centrifugation only when fungal cultures are specifically ordered by clinicians, or to use lysis-centrifugation as the routine blood culturing technique.
Cultures of Intravascular Devices
In a febrile patient with a complex clinical course, cultures of intravascular catheter tips can be important in determining whether the catheter insertion site is infected and acting as a portal of entry for an organism. Quantitative culturing is essential to distinguish between contaminants picked up from the skin when the catheter is removed and actual colonization of the catheter tip. Unfortunately, the cutoff values for discriminating infection from contamination have been well established for bacteria but not for Candida spp. At present, one must use these cutoffs as a guide in interpreting cultures that grow yeasts. In the technique of Maki et al. (69) , the catheter is rolled over the surface of an agar plate; >15 CFU of an organism has been statistically correlated with localized inflammation or systemic infection. Brun-Buisson et al. (14) recommend a more traditional quantitative technique. The catheter segment is sectioned and placed in a tube containing 1 ml of sterile water. The tube is mixed on a Vortex mixer for 1 min and 0.1 ml is spread over an agar plate with a sterile Pasteur pipette which has been bent into a U shape. They found that counts of i103 CFU bacteria per ml were 97.5% sensitive and 88% specific for a catheter-related infection. Their study included only one case of C. albicans catheter sepsis, and the catheter grew 3.8 x 102 CFU/ml.
DIAGNOSTIC METHODS OTHER THAN CULTURES Fluorescence Microscopy to Detect Organisms in Specimens
Reagents for direct or indirect fluorescent-antibody staining of Candida species are not available commercially. However, rabbit serum with a high antibody titer to C. albicans will recognize all Candida species when used in an FIG. 1 . Immunofluorescent staining of Candida organisms. A needle biopsy of a granulomatous lesion from the liver of a patient with acute leukemia was quite friable. Several tiny particles of the biopsy fell into the saline solution in which it was originally placed. These were homogenized in 0.1 ml of saline and applied to slides. After air drying, the slides were fixed in ethanol and stained with fluorescein-labeled rabbit anti-Candida antibodies. Several fields showed blastospores with attached germ tubes (original magnification, x 1,000). The remainder of the biopsy, which was submitted for histologic examination, showed what appeared to be the edges of an inflammatory lesion. Presumably, the organisms were present in the necrotic material that was stained by the fluorescent antibodies. A second biopsy submitted for culture failed to grow any organisms.
indirect fluorescent-antibody stain of infected tissues. We have found fluorescent-antibody staining useful in the diagnosis of Candida hepatitis (unpublished observations). As described, the liver is efficient in killing Candida spp.; therefore, when only a few millimeters of biopsy tissue is cultured, the organism may not be recovered. The yeast can be difficult to find in histologic sections. The density of organisms in the tissue may be low, and they will be missed unless multiple sections are examined. Also, the organism may be present in necrotic material which will detach from the specimen and not be processed by histologic techniques. A fluorescent-antibody-stained smear prepared from a homogenate of a portion of the biopsy specimen can help diagnose the infection when both cultures and histologic examinations are negative (Fig. 1) (1, 2, 5, 25, 44, 46, 47, 59, 91, 111, 113, 117) . In some, agglutination of C. albicans blastospores was used as the assay for antibodies (46, 91) . In many of these studies, remarkably high test sensitivities and specificities were claimed (25, 91, 117) . The studies were flawed in several ways. The crude antigen preparations used in different laboratories could not be standardized to enable good test reproducibility among laboratories. Although the positive precipitin tests obtained with a yeast cytoplasmic extract were said to enable one to discriminate between tissue invasion and colonization with Candida spp. because they detected antibodies against internal antigens of the microorganism, definitive proof of this was not obtained (59) . More recent work has shown that cytoplasmic extracts contain appreciable amounts of cell wall mannan (CWM), a polysaccharide antigen abundant in Candida cell walls (48, 49) . In addition, these earlier studies were biased because sera from patients with severe invasive candidiasis were often used to assess the sensitivity of the assays whereas their specificity was determined with sera from healthy volunteers as controls (1, 2, 5, 25, 46, 111, 113, 117) .
After 1980, attention was directed towards using defined purified antigens in the immunoassays and assessing their sensitivity and specificity in a more rigorous way. CWM of C. albicans shares antigenic determinants with CWM from other Candida species, and large amounts of highly purified CWM could be readily obtained. By using RIA and EIA, anti-CWM antibodies (anti-CWM) have been shown to be ubiquitous in human sera (21, 40, 48, 49, 58, 73) . Anti-CWM appears to be one of the major antibody species in human sera. In any defined population, anti-CWM levels are usually distributed about a mean; sera having the highest levels give positive precipitin tests when tested against CWM (49) . When anti-CWM levels were measured in serially drawn sera from neutropenic patients, a frequency distribution plot showed that antibodies from patients with invasive candidiasis were elevated and tended to skew the normal distribution curve to the right; however, a clear bimodal distribution of anti-CWM values was not observed (40) . Therefore, to use anti-CWM measurements diagnostically, it was necessary to establish a cutoff value for anti-CWM levels that gave acceptable test sensitivity and specificity. When this was done, the best observed sensitivity was about 65% (40) . In a significant number of patients, the test did not become positive until after a tissue biopsy diagnosis was made.
Counterimmunoelectrophoresis has been used to detect antibodies against multiple components of a cytoplasmic extract; the method is two-to fourfold more sensitive than conventional agar gel precipitin testing (24) . Sera from patients with invasive candidiasis yielded more precipitin lines by counterimmunoelectrophoresis than sera from uninfected controls (5, 24) . Cytoplasmic extracts were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and Western blots (immunoblots) of the resultant gels were probed with sera from infected and uninfected patients. This analysis revealed immunodominant cytoplasmic protein antigens that had molecular weights of 40,000 to 60,000 (41, 49, 71, 116) . When CWM-free preparations enriched for these antigens were used as targets in RIA or EIA, antibodies against them could be detected in 25 to 70% of sera from neutropenic patients with invasive candidiasis.
Thus, to measure anti-Candida antibodies reliably, one must perform assays that are relatively time-consuming for which neither the requisite purified antigens nor test kits are commercially available. Antibody testing is unlikely to be useful in highly immunosuppressed patients, such as neutropenic bone marrow transplant recipients, who are at greatest risk for invasive candidiasis. In other patient populations, such as intensive care patients, who appear to mount antibody responses more reliably, it is not clear that performing an antibody assay adds much to the data base of accumulated culture reports that a clinician would use in making therapeutic decisions.
Detection of Candida Antigens in Sera
Since 1976, several investigators have reported attempts to develop immunoassays for detecting C. albicans antigens in sera from infected patients (3, 6, 9, 17, 19, 26, 28, 35-37, 42, 52, 62, 73, 75, 81, 102, 112, 123, 125, 126) . The simple (11) 34 (206) a The last seven studies deal with use of the commercially available CAND-TEC test (Ramco Laboratories Inc., Houston, Tex.). It should be noted that, in addition to the differences shown, the two LA tests described in the two studies preceding these in the table (references 6 and 52) used beads sensitized with an IgG fraction, whereas the CAND-TEC beads (based on reference 37) are sensitized with whole serum. In the LA study described in reference 17 it was not possible to determine the number of controls used to calculate the percentages shown.
b HAI, hemagglutination inhibition; EIA-D, direct-sandwich EIA; EIA-I, antigen inhibition EIA; RIA-D, direct-sandwich RIA; RIA-I, antigen inhibition RIA.
Rab, rabbit; WCE, whole-cell extract; B, blastospores; Adj, adjuvant; i.m., intramuscularly; i.v., intravenously.
d Leuk, Neutropenic leukemics; lymph, lymphoma patients; mixed, mixture of underlying diagnoses.
latex agglutination (LA) tests for detecting Cryptococcus neoformans polysaccharide in cerebrospinal fluid had proved extraordinarily useful in diagnosing cryptococcal meningitis, and it was thought that a similar assay for detecting a Candida antigen in sera from patients with invasive candidiasis could be developed. (126) , it became evident that anti-CWM and other CWM-binding proteins are present in human sera which prevent detection of this antigen in nearly all patients (49, 125) . Therefore, detection of CWM is possible only when sera are treated to destroy these binding proteins before testing for CWM. Addition of acid, base, or proteolytic enzyme, followed by heating or boiling and then centrifugation, have been used to accomplish this goal (6, 28, 35, 52, 62, 73, 102, 125) . The resultant supernatant is assayed for antigen.
In experimental animal models of candidiasis and in studies of infected humans, it became evident that CWM is cleared rapidly from the serum (48) . Even in severe infections, CWM levels rarely reach 100 ng/ml (48) . Because anti-CWM antibodies raised in rabbits or obtained from mouse hybridomas have low avidity for CWM, assay systems have been used to detect antigen levels near the threshold of their sensitivities. Not surprisingly, detection of CWM is specific for the diagnosis of invasive candidiasis; however, reported diagnostic sensitivities have ranged between 22 and 100%. The lowest diagnostic sensitivities have been seen in patients from whom only one or two serum samples were assayed at the time infection was suspected. The best sensitivities were seen in neutropenic patients from whom serial specimens had been obtained weekly. The three largest studies (6, 52, 73 ) that used sequential serum assays had diagnostic sensitivities of 65 to 100%. These data suggest that diagnostic sensitivity is about 70% when sera from patients at risk for developing invasive candidiasis are assayed weekly. Because of the inconvenience associated with sample preparation and the difficulties associated with using immunoassays near the threshold of their sensitivities, commercial preparation of a CWM detection kit has not been possible.
Assays thought to detect antigens other than CWM have been developed that use rabbit antibodies raised by intramuscular injection of whole-cell extracts of C. albicans in an adjuvant. The ability of an assay to detect Candida antigens is verified by noting whether the antigen preparation used for immunization can be detected. The immunization procedure VOL. 3, 1990 on October 16, 2017 by guest http://cmr.asm.org/ Downloaded from favors production of antiprotein antibodies. Also, because sera are not pretreated before the assay is done, detection of CWM would be very unlikely. The sensitivity of these assays has ranged from 55 to 100%. Each laboratory has used a different type of assay system (hemagglutination inhibition, EIA, RIA, or LA), so it is difficult to make comparisons. Although monoclonal antibodies against cytoplasmic antigens have been produced (115) , their successful application in an immunoassay to detect antigens in human sera has not been described.
The only commercially available antigen detection assay for use in diagnosing candidiasis is an LA test (CAND-TEC; Ramco Laboratories Inc., Houston, Tex.), which is based on work described by Gentry et al. in 1983 (37) . Latex particles are sensitized with sera from rabbits immunized intramuscularly with a heat-killed suspension of C. albicans blastospores. The nature of the antigen detected by this assay has not been determined. We could not produce agglutination of CAND-TEC beads with either purified CWM or a whole-cell cytoplasmic extract of C. albicans at concentrations ranging from 1 ng to 1 mg/ml (unpublished observations). In a rat model of disseminated candidiasis, Greenfield et al. (42) detected either CWM by EIA or mannose by high-pressure liquid chromatography, but the CAND-TEC test applied to the same sera was uniformly negative. Therefore, this test may detect a neoantigen of C. albicans which requires some action of human host cells on the organism before it is detected. Alternatively, the antigen could be some material released from the human host during invasive candidiasis which happens to be detected by antibodies stimulated by heat-killed C. albicans in a rabbit.
The usefulness of the CAND-TEC assay for diagnosis of invasive candidiasis in patients with a variety of underlying diseases has been explored in four studies (19, 36, 37, 52) . The authors reported diagnostic sensitivities between 19 and 91% and specificities between 89 and 95%. In each of these studies, different criteria for diagnosing invasive candidiasis were used, and in many instances the descriptions of patients with invasive candidiasis were too limited to confirm that they had invasive infection rather than colonization or superficial infection by Candida spp. Also, in three studies (19, 36, 37) , the control sera tested were from either healthy volunteers or patients who were not clearly matched with the infected patients for underlying disease. These problems make these studies different to interpret.
In three studies focusing on use of the CAND-TEC test in patients with acute leukemia (6, 52, 81) , its diagnostic sensitivity ranged between 23 and 55%, while specificity ranged between 66 and 100%. Diagnostic sensitivity tended to increase as the number of sera tested per patient increased. However, as the number of sera per patient increased, the specificity also fell appreciably. Ness (27) . Finally, arabinitol is cleared by the kidneys with approximately the same efficiency as creatinine. Patients with renal failure will have higher arabinitol levels and the ratio of arabinitol to creatinine must be used to interpret any observed concentration of arabinitol (39, 130) .
Comparisons between metabolite determinations and antigen detection for the diagnosis of invasive candidiasis have been made in only one study (28) . Sera from 50 healthy blood donors and 38 high-risk patients, 23 with and 15 without invasive candidiasis, were analyzed by gas-liquid chromatography for arabinitol and mannose content and by EIA for detectable CWM. Arabinitol and mannose levels and the arabinitol/creatinine ratios were significantly higher in the high-risk patients without candidiasis than in healthy blood donors. Diagnostic utility (sensitivity/specificity) was as follows: for elevated arabinitol, 26/87%; for elevated arabinitol/creatinine ratio, 13/93%; for elevated mannose, 39/ 87%; and for CWM detection, 65/100%.
Aside from the above considerations, the greatest drawbacks to gas-liquid chromatography are the long time required to perform an assay and the complexity of the equipment used. Only a single specimen can be assayed at a time, and perhaps only six to eight specimens could be assayed in a working day.
Typing C. albicans Strains and Use of DNA Probes
Derived from C. albicans
For years it has been assumed that, when a patient becomes infected with C. albicans, the infecting strain is one with which the patient has been chronically colonized. Until recently, systems for typing C. albicans isolates were not available, so this hypothesis could not be challenged. Routine sugar assimilation or fermentation tests cannot distinguish strains, and only two CWM serotypes were recognized. Phenotypic and genotypic methods are now available for typing C. albicans.
Since C. albicans is a diploid eucaryote, recessive and dominant gene expression is possible and stable nonlethal mutations in a single cell can be passed on to its progeny. Therefore, different phenotypes can be observed when appropriate observations are made. Two approaches to phenotypic typing have been attempted. The first involves noting the growth characteristics of isolates replica plated onto different indicator or selective media. Patterns of growth characteristics on the different media are coded to yield biotypes (83, 84) or resistograms (122) . Only a few laboratories have used these typing techniques because preparation and reading of the plates require great care. Also, although >500 biotypes are hypothetically possible, biotypes cluster into about 20 groups with similar phenotypes (85). Odds et al. (86) recently reported using a biotyping method to type 18 coded C. albicans isolates in four laboratories. The biotyping system gave excellent intralaboratory reproducibility; however, concordance of data among laboratories was poor. A related typing technique has been described by Slutsky et al. (103) and Soll et al. (104, 105) . When a single colony of an isolate is plated onto an amino acid-rich defined medium and incubated at 240C, a variety of distinct colony morphologies is seen, each occurring at a particular frequency. When colonies on this plate are picked and replated, a pattern of different colony morphologies is again seen. A rapid genetic switching mechanism is responsible for the varying colony morphology. Isolates differ in the repertoire of colony morphologies to which they can switch, and the observed repertoire itself amounts to a phenotype. Obviously, this typing method is very laborious and is useful mainly as a tool for genetic studies of the fungus. In the second approach to phenotyping, whole-cell extracts of isolates are applied to sodium dodecyl sulfate-polyacrylamide gels and the patterns of protein bands are compared (71, 120) .
Several approaches have been used for genotyping C. albicans. In the first, whole-cell DNA extracts of isolates are digested with a restriction endonuclease, usually a tetraschizomer. Digests are separated electrophoretically in agar gels, and the restriction fragment length patterns (RFLPs) are read directly (100, 120) . Alternatively, Southern blots of the gels are probed with cloned fragments of a representative strain (34, 67, 101, 104, 105) . The cloned fragments are generally of relatively large size and are repeated within the genomic DNA. The number of RFLPs recognizable by inspection of agar gels is limited; however, when probes are used, very large numbers of RFLPs can be seen on blots. In some instances, the RFLP obtained from an isolate that has been passaged multiple times in the laboratory differs from that seen when the microbe was originally isolated (101 Although a good deal of research has been directed at developing diagnostic tests to detect anti-Candida antibodies or Candida antigens in sera, it has not been possible to develop tests with requisite simplicity, sensitivity, and specificity for the clinical microbiology laboratory. Before detection of metabolites of Candida spp. in sera by gas-liquid chromatography could be used in the microbiology laboratory, technical issues related to derivatization of the metabolites must be resolved. The time required to process specimens and the complexity of the instruments required for high-pressure liquid chromatography analysis will make practical application of this technology difficult.
The ability to type isolates of C. albicans has already led to interesting observations regarding its transmission within the hospital; however, it seems unlikely that any of the typing techniques presently available will be used as anything but research tools for the forseeable future.
The future role of the microbiology laboratory in diagnosis of invasive candidiasis could be influenced by research directed at answering a number of questions. For example, how does drawing blood cultures frequently, on a scheduled basis, from patients at high risk for developing candidiasis (e.g., neutropenic patients with leukemia or intensive care unit patients) influence the likelihood of detecting Candida fungemia compared with an approach in which blood cultures are drawn only when infection is clinically suspected?
If scheduled blood cultures are drawn, do lysis-centrifugation cultures detect more episodes of fungemia than broth cultures? Can one establish cutoff values for interpreting growth of Candida spp. from quantitative cultures, tissue biopsies, or BAL specimens? Can a C. albicans antigen be found that is released during tissue invasion but fails to bind to anti-Candida antibodies or other serum proteins so that it can be detected in serum that was not pretreated to destroy antibodies? It is hoped that answers to these questions will be forthcoming during the next several years.
